Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck & Co. synthesizes novel histamine H3 receptor antagonists

June 9, 2011

SPX-106 with D-tagatose significantly reduces cholesterol and triglycerides in mice

June 7, 2011

Mellitech researchers disclose new insulin secretagogues

June 7, 2011

Liraglutide added to insulin shows promise in treating type 1 diabetes

June 7, 2011

Vitae and Boehringer Ingelheim claim new 11-beta-HSD1 inhibitors

June 7, 2011

Orexigen Therapeutics to appeal FDA's decision regarding Contrave NDA

June 6, 2011

Phase III Get-Goal-L trial of lixisenatide in type 2 diabetes meets primary endpoint

June 6, 2011

New ghrelin receptor antagonists and/or inverse agonists synthesized

June 3, 2011

Diamyd Medical stops follow-up in European phase III study of Diamyd in diabetes

June 1, 2011

European Commission approves extended use of Carbaglu for organic acidemias

June 1, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...